Genetic Testing

Myriad Genetics and Leading Cancer Center Collaborate to Study the Use of Minimal Residual Disease Testing in Breast Cancer

Research will use Myriad’s high-definition MRD testing platform based on whole-genome sequencingSALT LAKE CITY, Sept. 18, 2023 (GLOBE NEWSWIRE) --…

1 year ago

Baylor Genetics Announces Neurodevelopmental Disorders Test Panel to Help Healthcare Providers Diagnose Patients with Intellectual Disabilities or Developmental Delays

New Test Analyzes Highly Curated Set of 236 Genes Most Associated with Autism Spectrum Disorder, Intellectual Disabilities, and Developmental Delay.HOUSTON,…

1 year ago

GeneDx Announces Evolution of Executive Leadership Team

Melanie Duquette joining team as Chief Growth Officer to drive commercial excellence, Jennifer Brendel to take new role as Chief…

1 year ago

Applied DNA Advances Commercialization of Linea(TM) IVT Platform, Appoints Beverly Wolgast as Executive Director of Quality and cGMP Programs

Experienced Biopharma/Pharmaceutical Executive to Lead Implementation of cGMP-quality LineaDNA™ Capability for IVT mRNA ProductionPreviously Led Manufacturing Operations Scale-up for the…

1 year ago

MindBio Therapeutics Announces Major Genetic Discovery in Microdosing Research

Genetic Discovery: MindBio's genetic testing in clinical research yields novel discovery for targeted diagnosis and treatmentSignificant Intellectual Property & Know…

1 year ago

Annual Results – Momentum Building on our Commercial Plans

MELBOURNE, Australia, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader…

1 year ago

Applied DNA Announces Availability and First Customer Shipment of New Linea(TM) IVT Evaluation Kit

STONY BROOK, NY / ACCESSWIRE / August 29, 2023 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"),…

1 year ago

Applied DNA Files Provisional Patent Applications for Methods of Double-Stranded RNA Mitigation in Next-Generation mRNA Production

STONY BROOK, NY / ACCESSWIRE / August 23, 2023 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"),…

1 year ago

In Collaboration With JScreen, Cancer Warrior Lainie Jones Advocates for Genetic Testing

ATLANTA, GA / ACCESSWIRE / August 22, 2023 / The story of Lainie Jones, a cancer survivor from Fort Lauderdale,…

1 year ago

Myriad Genetics and Onsite Women’s Health Partner to Help More Women Understand Breast Cancer Risk

New collaboration increases access to genetic testing and can help identify patients with a high-risk for breast cancerSALT LAKE CITY,…

1 year ago